USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2023-11-13 обновлены отчеты компании ELOX: 2023-Q32022-Q42022-Q3
Eloxx Pharmaceuticals logo
Eloxx Pharmaceuticals ELOX
$ 3.82 -5.68%

Eloxx Pharmaceuticals Мультипликаторы 2011-2024 | ELOX

Мультипликаторы по годам Eloxx Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.2 -0.0 -4.0 -2.9 -7.9 -1.1 -0.4 -0.6 -1.2 -0.7 -4.4 -2.5

P/S

- - - - - - 48.8 142.2 113.9 - 111.4 -

EPS

-16.6 -38.1 -0.9 -1.3 -1.4 -4.8 -2.6 1.7 -2.5 -5.1 -7.8 -0.1

EV (Enterprise Value)

18.7 млн -18.3 млн 130 млн 149 млн 333 млн -12.6 млн 6.11 млн 14.7 млн 11.1 млн 5.81 млн 23.8 млн 18.5 млн

EBITDA per Share

-15.8 -37.7 -0.832 -1.31 -1.44 -1.81 -3.56 -10.6 -24.1 -62.8 -113 -178

EV/EBITDA

0.3 -3.6 -2.8 -7.0 -3.3 -0.8 -1.0 -0.8 -1.1 -4.7 -2.7

PEG

-0.0 -0.0 -0.11 -0.39 -0.11 -0.03 -0.01 -0.01 -0.02 -0.02 -0.1 -0.03

P/B

-0.6 0.1 13.5 4.1 8.7 7.5 0.8 0.9 0.4 1.1 6.5 4.0

P/CF

-0.2 -0.0 -4.9 -3.8 -11.8 -3.4 -1.0 -1.4 -2.1 -0.9 -4.6 -3.0

ROE %

338.32 -298.10 -338.00 -140.49 -109.96 -665.33 -181.29 -147.76 -33.56 -161.71 -146.72 -160.91

ROA %

-170.74 -147.83 -130.59 -86.30 -93.03 -99.16 -89.62 -92.41 -27.67 -86.26 -72.84 -84.55

ROCE %

322.88 -294.93 -201.06 -107.24 -109.46 -69.76 -41.93 -40.83 -21.97 -118.03 -134.26 -118.81

Current Ratio

0.7 2.0 2.6 4.9 6.4 0.1 2.7 4.8 4.0 1.1 1.1 1.5

DSO

- - - - - - - - 157.4 - - -

DIO

- - - - - - - - - - - -

DPO

- - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Eloxx Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.31 -1.96 -2.88 - -3.47 -4.9 -5.36 - -0.11 -0.54 -0.22 - -0.16 -0.2 -0.35 - -0.32 -0.4 -0.33 - -0.32 -0.42 -0.31 - -1.15 -1.04 -0.03 -0.04 -0.05 -0.08 -0.15 -0.19 -0.02 -0.19 -0.02 -0.78 -0.38 -0.78 -0.38 -0.48 -0.78 -0.48 -0.78 -1.11 -2.52 -0.01 -0.03 -0.02 -0.02 -0.02 -0.02

EBITDA per Share

- - -2.52 - -3.29 -4.74 -5.05 - -0.12 -0.54 -0.21 - -0.16 -0.19 -0.34 - -0.32 -0.39 -0.33 - -0.32 -0.42 -0.31 - -0.95 -0.75 -0.01 -0.07 -0.11 -0.18 -0.24 -0.18 -0.06 -0.18 -0.06 -0.78 -0.37 -0.77 -0.37 -0.44 -0.73 -0.42 -0.73 -1.05 -1.1 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02

ROE %

153.73 286.51 -322.81 -534.72 -564.67 -745.33 -248.07 -434.82 -499.50 -534.23 -522.61 -278.10 -313.66 -284.53 -247.33 -108.36 -134.37 -124.83 -116.17 -77.27 -126.89 -119.80 -106.71 -92.62 -172.48 -179.31 -221.79 -236.33 -706.45 -682.15 -665.70 -646.71 -434.36 -456.03 -501.84 -519.22 -152.95 -214.11 -166.88 -195.15 -254.50 -249.54 -243.54 -256.81 -230.40 -177.50 -174.54 -137.15 -26.42 -33.81 -23.00

ROA %

-246.35 -214.83 -174.63 -86.81 -104.65 -94.57 -121.83 -120.03 -145.02 -152.16 -122.46 -107.45 -129.29 -126.14 -120.87 -66.57 -88.58 -88.74 -90.66 -65.38 -108.15 -102.44 -91.66 -79.83 -62.31 -59.32 -73.36 -78.36 -77.76 -65.37 -55.42 -46.22 -79.50 -96.99 -109.50 -124.13 -80.80 -93.06 -83.64 -93.23 -101.89 -104.51 -99.95 -104.80 -103.83 -83.08 -82.59 -64.69 -12.56 -17.77 -12.09

ROCE %

150.11 275.32 -315.15 -518.58 -549.63 -724.03 -243.73 -424.92 -486.46 -516.96 -503.21 -270.27 -305.56 -279.31 -244.67 -107.88 -134.35 -125.54 -117.58 -77.95 -96.68 -88.93 -72.25 -36.55 -283.67 -325.92 -441.84 -546.10 -883.44 -831.68 -743.95 -646.16 -448.98 -462.90 -509.84 -519.28 -152.58 -212.23 -164.19 -191.62 -253.27 -217.88 -213.57 -203.36 -172.52 -157.68 -152.26 -144.51 -32.55 -32.23 -28.34

Current Ratio

0.2 0.2 0.3 0.7 0.8 1.1 1.4 2.0 2.5 3.0 1.2 1.6 1.6 1.6 1.6 2.6 2.6 2.6 2.6 6.5 - - - - 7.6 5.0 7.6 1.1 2.1 1.2 2.0 2.3 2.8 2.7 2.7 2.8 4.9 5.7 5.7 3.3 1.6 2.1 2.1 1.4 1.7 2.0 2.0 1.7 1.9 2.1 2.1

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD